Quarterly report pursuant to Section 13 or 15(d)

Licenses and Collaborations (Details Narrative)

v2.4.0.8
Licenses and Collaborations (Details Narrative) (USD $)
In Millions, except Share data, unless otherwise specified
Dec. 31, 2013
Licenses And Collaborations Details Narrative  
Additional exercisable options $ 7.5
Common stock purchased by Teva 687,442